Sartorius Stedim Biotech S.A. (EPA:DIM)
197.50
-6.90 (-3.38%)
At close: Jan 28, 2026
Sartorius Stedim Biotech Employees
Sartorius Stedim Biotech had 10,134 employees as of September 30, 2025. The number of employees increased by 52 or 0.52% compared to the same quarter last year.
Employees
10,134
Change
52
Growth
0.52%
Revenue / Employee
€290,764
Profits / Employee
€26,041
Market Cap
19.22B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Sep 30, 2025 | 10,134 | 52 | 0.52% | 10,134 | 0 |
| Jun 30, 2025 | 10,030 | -352 | -3.39% | 10,030 | 0 |
| Mar 31, 2025 | 9,961 | -532 | -5.07% | 9,961 | 0 |
| Dec 31, 2024 | 9,901 | -761 | -7.14% | 9,901 | 0 |
| Sep 30, 2024 | 10,082 | -767 | -7.07% | 10,082 | 0 |
| Jun 30, 2024 | 10,382 | -753 | -6.76% | 10,382 | 0 |
| Mar 31, 2024 | 10,493 | -1,441 | -12.07% | 10,493 | 0 |
| Dec 31, 2023 | 10,662 | -1,272 | -10.66% | 10,662 | 0 |
| Sep 30, 2023 | 10,849 | -1,093 | -9.15% | 10,849 | 0 |
| Jun 30, 2023 | 11,135 | -807 | -6.76% | 11,135 | 0 |
| Dec 31, 2022 | 11,934 | 1,525 | 14.65% | 11,934 | 0 |
| Jun 30, 2022 | 11,942 | 3,196 | 36.54% | 11,942 | 0 |
| Mar 31, 2022 | 11,400 | 3,200 | 39.02% | 11,400 | 0 |
| Dec 31, 2021 | 10,409 | 2,843 | 37.58% | 10,409 | 0 |
| Sep 30, 2021 | 9,619 | 2,640 | 37.83% | 9,619 | 0 |
| Jun 30, 2021 | 8,746 | 2,056 | 30.73% | 8,746 | 0 |
| Mar 31, 2021 | 8,200 | 2,000 | 32.26% | 8,200 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| EssilorLuxottica Société anonyme | 200,076 |
| emeis Société anonyme | 83,500 |
| Sanofi | 82,878 |
| Eurofins Scientific SE | 65,000 |
| Clariane SE | 61,798 |
| Ramsay Générale de Santé | 40,494 |
| bioMérieux | 14,754 |
| Virbac | 6,365 |
Sartorius Stedim Biotech News
- 3 months ago - Q3 2025 Sartorius AG and Sartorius Stedim Biotech SA Earnings Call Transcript - GuruFocus
- 3 months ago - Sartorius Stedim (SDMHF) Reports Strong Q3 Earnings and Updates Guidance - GuruFocus
- 3 months ago - Sartorius Stedim Biotech Non-GAAP EPS of €0.94, revenue of €705.7M; raises FY outlook - Seeking Alpha
- 3 months ago - Sartorius Stedim Biotech Earnings Up In H1; Lifts FY25 Outlook - Nasdaq
- 6 months ago - Sartorius Stedim Biotech and Nanotein Technologies Partner to Advance Cell Therapy Manufacturing - Business Wire
- 6 months ago - Bio Usawa Biotechnology and Sartorius Stedim Biotech Forge Partnership to Pioneer Biopharmaceutical Manufacturing in Africa - GlobeNewsWire
- 7 months ago - Sartorius Stedim Biotech and Sensible Biotechnologies Partner to Scale Up Sensible's Unique Cell-Based mRNA Design and Manufacturing Platform - Business Wire
- 1 year ago - Sartorius Stedim Biotech SA (SDMHF) Q4 2024 Earnings Call Highlights: Navigating Growth Amid ... - GuruFocus